Molecular typing is based on molecular genetic screening and is not however routinely offered. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 can be https://friedrichu874jwg1.salesmanwiki.com/user